<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362630">
  <stage>Registered</stage>
  <submitdate>4/07/2012</submitdate>
  <approvaldate>5/07/2012</approvaldate>
  <actrnumber>ACTRN12612000717853</actrnumber>
  <trial_identification>
    <studytitle>Fluid restriction compared to fluid optimisation with the oesophageal doppler in colorectal surgery: a randomized clinical trial of efficacy</studytitle>
    <scientifictitle>The effect of fluid optimisation with the oesophageal doppler compared to fluid restriction on perioperative morbidity in major elective colorectal surgery with an Enhanced Recovery After Surgery protocol.</scientifictitle>
    <utrn>U1111-1131-8049</utrn>
    <trialacronym>RESORT

"RES"trictive "OR T"argetted</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Colorectal surgery</healthcondition>
    <healthcondition>Fluid therapy intraoperative</healthcondition>
    <healthcondition>Perioperative morbidity</healthcondition>
    <healthcondition>Haemodynamic state intraoperative</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Anaesthetics</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Other surgery</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The fluid optimisation group will have an oesophageal doppler inserted after induction.  A maintenance rate of Hartmann's solution at 6mls/kg/hr will run intravenously at the start to the end of the operative period.  The anaesthetist will use the oesophageal doppler to administer colloid boluses intravenously (250mls Hydroxyethyl starch 130/0.4, Volulyte, Fresenius Kabi) based on the stroke volume and flow time parameters.</interventions>
    <comparator>The control group will have a "restrictive" fluid regimen as follows:
Maintenance 6mls/kg/hr Hartmann's solution with boluses to replace blood loss.  Boluses can be crystalloid or colloid or blood.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Complication rate: number of complications during hospital stay.
We will use a standardised classfication and severity grading scale, based on the work of Dindo and Clavien.
This has a 17 point classification of complications (eg. Venous thromboembolism, sepsis, AMI).  The severity grading scale is a 7 point scale (from I - deviation from normal postoperative course without the need for intervention to V-death).  Further details can be found at http://www.surgicalcomplication.info</outcome>
      <timepoint>During duration of hospital stay.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Length of hospital stay (from date of admission to date of discharge)</outcome>
      <timepoint>From date of admission to date of discharge</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in Velocity Time Integral on Doppler examination across the Left Ventricular Outflow Tract.</outcome>
      <timepoint>At the beginning and end of surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Change in the stroke volume and cardiac output using intraoperative trans thoracic echocardiography.</outcome>
      <timepoint>At the beginning and end of surgery</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Volume of fluid administration</outcome>
      <timepoint>Intraoperative</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Vasopressor use</outcome>
      <timepoint>Intra-operative and until discharge from the recovery unit.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Elective major colorectal surgery
&gt;18yrs of age
Enrollment into the Enhance Recovery After Surgery clinical care pathway.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Emergency surgery
Significant renal impairment
Hepatic dysfunction
Oesophageal pathology that is a contraindication to a oesophageal doppler probe
Inability to give informed consent
Pregnancy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed opaque envelopes</concealment>
    <sequence>Permuted block randomisation</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>28/06/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>102</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Dr Tuong Dien Phan</primarysponsorname>
    <primarysponsoraddress>PO Box 2900
Department of Anaesthesia
St Vincent's Hospital
Fitzroy Victoria 3065</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>St Vincent's Hospital Research Endowment Fund</fundingname>
      <fundingaddress>41 Victoria Pde
Fitzroy Victoria 3065</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>During surgery on the bowel it is routine to replace blood and fluid loss with intravenous fluids.  However, it is still unclear what the optimal amount and method is to replace this loss.  This study compares giving a smaller amount of fluid, called fluid restriction, to giving fluid guided by a cardiac output monitor, called targetted fluid administration.  We will assess the impact these two methods have on patient's recovery and also the effect on observed clinical signs such as cardiac output at the end of the operation.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>St Vincent's HREC</ethicname>
      <ethicaddress>41 Victoria Pde
Fitzroy Victoria 3065</ethicaddress>
      <ethicapprovaldate>3/05/2012</ethicapprovaldate>
      <hrec>039_12</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>St Vincent's Private Ethics Committee</ethicname>
      <ethicaddress>59-61 Victoria Pde
Fitzroy Victoria 3065</ethicaddress>
      <ethicapprovaldate />
      <hrec>R0089/12</hrec>
      <ethicsubmitdate>26/06/2012</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Tuong D Phan</name>
      <address>Mail:
PO Box 2900
Department of Anaesthesia
St Vincent's Hospital
Fitzroy Vic 3065</address>
      <phone>+61 3 92882253</phone>
      <fax>+61 3 9288 4255</fax>
      <email>tuong.phan@svhm.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Tuong D Phan</name>
      <address>Mail:
PO Box 2900
Department of Anaesthesia
St Vincent's Hospital
Fitzroy Vic 3065</address>
      <phone>+61 3 92882253</phone>
      <fax>+61 3 9288 4255</fax>
      <email>tuong.phan@svhm.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Tuong D Phan</name>
      <address>Mail:
PO Box 2900
Department of Anaesthesia
St Vincent's Hospital
Fitzroy Vic 3065</address>
      <phone>+61 3 92882253</phone>
      <fax>+61 3 9288 4255</fax>
      <email>tuong.phan@svhm.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>